NASDAQ$ANIK
Anika Therapeutics Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Anika reported a 7% year-over-year revenue growth in the first quarter, driven by favorable order timing in OA Pain Management.
Anika Therapeutics reported a strong start to 2022 with a 7% year-over-year revenue growth. The company is experiencing healthy demand for OA Pain Management products and growing demand for the Joint Preservation and Restoration portfolio. They are ramping up medical education activities and planning new product introductions.
- First quarter revenue growth of 7% year-over-year.
- Growth driven by favorable order timing in OA Pain Management.
- Continued healthy demand for OA Pain Management products.
- Growing demand for Joint Preservation and Restoration portfolio.
Headline financials
Revenue & EPS history
Anika · Revenue · Quarterly
$36.7M
Forward guidance
The Company expects its overall revenue for fiscal year 2022 to be toward the upper end of its guidance range of low to mid-single digit percent growth compared with 2021.
Headwinds
- Volatility and uncertainty in the global macroeconomic environment.
- Staffing shortages.
- Supply chain disruption.
- Inflation.
- Direct and indirect impacts of the COVID pandemic.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2022
+0.1%
Avg return
Earnings day
-3.0%
Avg return
5 days after
-2.8%
Avg return
30 days after
51%
33 / 65 earnings
Positive
+32.1%
Q3 2019
Best reaction
-33.0%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -18.8% | -4.7% | -4.8% | |
| Q4 2025 | +16.8% | +31.6% | +30.5% | |
| Q3 2025 | +0.8% | -0.5% | +2.1% | |
| Q1 2025 | -20.7% | -23.2% | -23.0% | |
| Q4 2024 | -11.1% | -7.3% | -20.3% | |
| Q3 2024 | -33.0% | -34.0% | -28.2% | |
| Q2 2024 | -1.0% | -3.6% | -5.4% | |
| Q1 2024 | -10.9% | -9.9% | -9.1% | |
| Q4 2023 | -4.8% | -2.0% | -3.1% | |
| Q3 2023 | +7.4% | +6.7% | +15.2% | |
| Q2 2023 | -4.9% | -12.7% | -18.0% | |
| Q1 2023 | -2.8% | -3.2% | +3.2% | |
| Q4 2022 | -18.0% | -17.4% | -10.4% | |
| Q3 2022 | +0.3% | +5.3% | +6.3% | |
| Q2 2022 | -4.9% | -2.7% | -6.0% | |
| Q1 2022 | -4.9% | -3.8% | +1.1% | |
| Q4 2021 | -15.9% | -18.0% | -20.1% | |
| Q3 2021 | +3.1% | -8.2% | -12.8% | |
| Q2 2021 | +1.0% | +0.8% | +1.3% | |
| Q1 2021 | +1.3% | +2.8% | +10.9% | |
| Q4 2020 | -10.5% | -12.1% | +3.9% | |
| Q3 2020 | -3.3% | +0.2% | +7.6% | |
| Q2 2020 | +0.3% | -8.7% | +2.9% | |
| Q1 2020 | -9.9% | -12.2% | +9.1% | |
| Q4 2019 | +0.4% | +0.1% | -39.5% | |
| Q3 2019 | +32.1% | +21.5% | +3.7% | |
| Q2 2019 | +29.1% | +31.0% | +37.2% | |
| Q1 2019 | +19.6% | +21.5% | +15.9% | |
| Q4 2018 | -15.3% | -18.8% | -26.5% | |
| Q3 2018 | -11.0% | -13.6% | -13.9% | |
| Q2 2018 | +18.6% | +15.0% | +20.8% | |
| Q1 2018 | -22.9% | -15.7% | -8.6% | |
| Q4 2017 | -4.0% | -11.3% | -17.4% | |
| Q3 2017 | -8.0% | -9.2% | -8.0% | |
| Q2 2017 | +7.1% | +6.0% | +9.3% | |
| Q1 2017 | -5.5% | -1.8% | +0.4% | |
| Q4 2016 | -5.0% | -5.1% | -16.4% | |
| Q3 2016 | +2.0% | +2.7% | +8.0% | |
| Q2 2016 | -5.0% | -2.3% | -6.7% | |
| Q1 2016 | +0.5% | — | — | |
| Q4 2015 | +11.2% | — | — | |
| Q3 2015 | +12.5% | — | — | |
| Q2 2015 | +3.2% | — | — | |
| Q1 2015 | -7.5% | — | — | |
| Q4 2014 | -10.7% | — | — | |
| Q3 2014 | +1.0% | — | — | |
| Q2 2014 | +4.1% | — | — | |
| Q1 2014 | +7.7% | — | — | |
| Q4 2013 | +26.9% | — | — | |
| Q3 2013 | +6.5% | — | — | |
| Q2 2013 | +21.9% | — | — | |
| Q1 2013 | -1.8% | — | — | |
| Q4 2012 | +16.6% | — | — | |
| Q3 2012 | -7.7% | — | — | |
| Q2 2012 | +24.4% | — | — | |
| Q1 2011 | +0.6% | — | — | |
| Q1 2012 | +2.8% | — | — | |
| Q4 2009 | +1.5% | — | — | |
| Q4 2011 | +1.5% | — | — | |
| Q3 2011 | +7.0% | — | — | |
| Q3 2010 | +7.0% | — | — | |
| Q2 2010 | -3.4% | — | — | |
| Q4 2010 | -3.4% | — | — | |
| Q2 2011 | -3.4% | — | — | |
| Q1 2010 | -1.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro